
In 1986, Mosmann and Coffman proposed the classic binary model of CD4⁺ helper T cells, classifying them into Th1 and Th2 subsets based on their cytokine secretion profiles. This laid the foundation for adaptive immunity research. As research progressed, the scientific community elucidated the differentiation mechanisms, regulatory networks, and immune plasticity of Th1/Th2 cells.
Even with the subsequent discovery of novel T cell subsets such as Th17, Tfh, and Treg, the Th1/Th2 cytokine profile remains the most central and widely used testing system for assessing immune bias. It is extensively applied in infectious immunity, autoimmune diseases, allergies, oncology, reproductive immunology, and drug efficacy evaluation.
To address common questions in scientific research, this article systematically and concisely reviews the core mechanisms, immune imbalance mechanisms, and disease research value of Th1/Th2.
I. Core Mechanisms of Th1/Th2
Naive CD4⁺T cells (Th0) undergo directed differentiation under antigen stimulation and regulation by cytokines in the local microenvironment. The two major subsets mutually cross-inhibit each other to maintain immune homeostasis.

1. Th1Cell
Inducing cytokines: IL-12, IFN-γ, IL-18, IL-27, IL-23
Key transcription factors: TBX21, STAT1, STAT4
Signature effector cytokines: IFN-γ, TNF-α, TNF-β, IL-2, GM-CSF, IL-3
Chemokines and receptors: CXCR3, CCR5, CXCL10, CXCL9, CXCL11
Core functions: Mediates cellular immunity, macrophage activation, CD8⁺ T cell enhancement, and IgG2a class switching. It is essential for the clearance of intracellular bacteria (e.g., Mycobacterium tuberculosis, Listeria monocytogenes) and viruses (HSV, CMV, HBV).
Key transcription factors: TBX21, STAT1, STAT4
Signature effector cytokines: IFN-γ, TNF-α, TNF-β, IL-2, GM-CSF, IL-3
Chemokines and receptors: CXCR3, CCR5, CXCL10, CXCL9, CXCL11
Core functions: Mediates cellular immunity, macrophage activation, CD8⁺ T cell enhancement, and IgG2a class switching. It is essential for the clearance of intracellular bacteria (e.g., Mycobacterium tuberculosis, Listeria monocytogenes) and viruses (HSV, CMV, HBV).
2. Th2Cell
Inducing cytokines: IL-4, IL-25, IL-33, TSLP
Key transcription factors: GATA3, STAT6, IRF4
Signature effector cytokines: IL-4, IL-5, IL-13, IL-9, IL-10, IL-33, IL-25
Core functions: Mediates humoral immunity, eosinophil recruitment, IgE/IgG1 class switching, defense against helminth infections, and mucosal repair. Dysregulation of this response contributes to allergic inflammation, asthma, atopic dermatitis, and other diseases.
Key transcription factors: GATA3, STAT6, IRF4
Signature effector cytokines: IL-4, IL-5, IL-13, IL-9, IL-10, IL-33, IL-25
Core functions: Mediates humoral immunity, eosinophil recruitment, IgE/IgG1 class switching, defense against helminth infections, and mucosal repair. Dysregulation of this response contributes to allergic inflammation, asthma, atopic dermatitis, and other diseases.
3. Core balancing mechanism
IFN-γ derived from Th1 cells inhibits the differentiation of Th0 into Th2 cells. Conversely, IL-4 and IL-13 derived from Th2 cells inhibit the differentiation of Th0 into Th1 cells via the STAT6 pathway. These two axes—IL-12/IFN-γ and IL-4/IL-13—mutually antagonize each other, forming a classic negative feedback loop that maintains dynamic immune homeostasis.

II.Th1/Th2 dominance shift and associated disease spectrum

III.Quick Reference Guide to the Clinical Significance of Cytokines

IV. Breaking the Static Dichotomy: Modern Perspectives and Detection Strategies
The aforementioned cytokine profiles provide quantifiable indicators for clinical testing. However, a crucial point must be noted when interpreting the results: Th1/Th2 are not fixed, terminally differentiated subsets. The Th1/Th2 cytokine profile reflects the bias of the immune response rather than an absolute standard for cell classification. Traditional views held that Th1/Th2 were fixed, terminally differentiated subsets, but modern single-cell sequencing has confirmed the high plasticity of CD4⁺ T cells. A large number of IFN-γ⁺IL-4⁺ double-positive and T-bet⁺GATA3⁺ intermediate cells exist in vivo, and their differentiation states are dynamically regulated by the local microenvironment.
Scientific research and testing require comprehensive verification using flow cytometry staining for both T-bet/GATA3 transcription factors and chemokine receptors (CXCR3/CCR4). Relying solely on cytokines for determination is insufficient. A multi-parameter testing strategy is recommended: intracellular flow cytometry staining to detect IFN-γ, TNF-α, IL-2, IL-4, IL-5, IL-13, IL-9, and IL-10; multiplex cytokine detection in supernatants (Luminex/MSD) to simultaneously quantify the aforementioned factors along with IL-12p70 and CXCL10; and concurrent measurement of the proportion of Tregs (Foxp3⁺) and their secreted IL-10/TGF-β levels to rule out interference from immunosuppression.
By comprehensively analyzing the dynamic changes in Th1/Th2 cytokine profiles and their ratios, combined with the expression profiles of transcription factors and chemokine receptors, one can accurately decipher the body's immune bias. This provides a crucial basis for mechanistic research and precision diagnosis and treatment in the fields of infection, autoimmunity, allergy, oncology, and reproductive medicine.
Scientific research and testing require comprehensive verification using flow cytometry staining for both T-bet/GATA3 transcription factors and chemokine receptors (CXCR3/CCR4). Relying solely on cytokines for determination is insufficient. A multi-parameter testing strategy is recommended: intracellular flow cytometry staining to detect IFN-γ, TNF-α, IL-2, IL-4, IL-5, IL-13, IL-9, and IL-10; multiplex cytokine detection in supernatants (Luminex/MSD) to simultaneously quantify the aforementioned factors along with IL-12p70 and CXCL10; and concurrent measurement of the proportion of Tregs (Foxp3⁺) and their secreted IL-10/TGF-β levels to rule out interference from immunosuppression.
By comprehensively analyzing the dynamic changes in Th1/Th2 cytokine profiles and their ratios, combined with the expression profiles of transcription factors and chemokine receptors, one can accurately decipher the body's immune bias. This provides a crucial basis for mechanistic research and precision diagnosis and treatment in the fields of infection, autoimmunity, allergy, oncology, and reproductive medicine.
V. Product Recommendation - Precise Testing Facilitates Scientific Decision-Making
For the detection of Th1/Th2-related cytokines, our company recommends the following ELISA kit products for you.

References:
[1] Mosmann TR, Cherwinski H, Bond MW, et al. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol. 1986;136 (7):2348-2357.
[2] Coffman RL, Carty J. A T cell activity that enhances polyclonal IgE production and its inhibition by interferon-gamma. J Immunol. 1986;136(3):949-954.
[3] Romagnani S. Th1 and Th2 in human diseases. Clin Immunol Immunopathol. 1996;80(3):225-235.
[4] Szabo SJ, Sullivan BM, Peng SL, Glimcher LH. Molecular mechanisms regulating Th1 immune responses. Annu Rev Immunol. 2003;21:713-758.
[5] Zhu J, Paul WE. Heterogeneity and plasticity of T helper cells. Cell Res. 2010;20(1):4-12.
[6] Locksley RM. T helper cell differentiation in infection and immunity. Annu Rev Immunol. 2009;27:521-552.
[7] O'Shea JJ, Paul WE. Mechanisms underlying lineage commitment and plasticity of helper CD4⁺ T cells. Science. 2010;327(5969):1098-1102.
[8] Zhu J. T helper cell differentiation, heterogeneity, and plasticity. Cold Spring Harb Perspect Biol. 2018;10(10):a030338.
[9] Wynn TA. IL-13 effector functions. Annu Rev Immunol. 2003;21:429-456.
[10] Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 Cells. Annu Rev Immunol. 2009;27:485-517.
[11] Yanuck SF. Failed Induction of the TH1 System in TH2 Dominant Patients: The Cancer-Permissive Immune Macroenvironment. Integr Med (Encinitas). 2024;23 (2):24–35.
[12] Robinson DS. Th2 cytokines and asthma—an update. Nat Rev Immunol. 2004;4 (1):25-34.
